Behavioral characterization of neuropeptide Y knockout mice

Brain Research

Volumn 868, Issue 1, 2000, Pages 79-87

  Bannon, A W ^a   Seda, J ^a   Carmouche, M ^a   Francis, J M ^a   Norman, M H ^a   Karbon, B ^a   McCaleb, M L ^a  

^a AMGEN INC   (United States)

Author keywords

Acoustic startle; Anxiety; Fasting; Knockout; Nociception; NPY

Indexed keywords

1 (3 METHOXYPHENYL) 1 (4 PHENYLPIPERAZIN 1 YL) 4 METHYL CYCLOHEXANE; [4 [(4 AMINO QUINAZOLIN 2 YLAMINO) METHYL] CYCLOHEXYLMETHYL] AMIDE; AMG 68; CGP 7163A; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; DIET RESTRICTION; FOOD INTAKE; HOT PLATE TEST; KNOCKOUT MOUSE; MAZE TEST; MOUSE; NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; STARTLE REFLEX;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; FASTING; FEMALE; HEAT; LOCOMOTION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; NOCICEPTORS; PAIN THRESHOLD; REACTION TIME; RECEPTORS, NEUROPEPTIDE Y; STARTLE REACTION;

EID: 0034674684     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02285-X     Document Type: Article

References (35)

1. Beck B., Stricker K.A., Nicolas J.P., Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behavior of obese Zucker rats. Int. J. Obes. 16:1992;295-302.
2. Brady L.S., Smith M.A., Gold P.W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 52:1990;441-447.
3. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus maze and fear-potentiated startle procedures. Behav. Pharmacol. 6:1995;215-222.
4. Colmers W.F., Wahlestedt C. The Biology of Neuropeptide Y and Related Peptides. 1993;Humana Press, New Jersey.
5. 5 receptor. J. Clin. Invest. 102:1998;2136-2145.
6. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15:1992;353-375.
7. Dube M.G., Xu B., Crowley W.R., Kalra P.S., Kalra S.P. Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res. 646:1994;341-344.
8. Dumont Y., Jacques D., St-Pierre J.-A., Quirion R. Neuropeptide Y receptor types in the mammalian brain: species differences and status in the human central nervous system. Grundemar L., Bloom S.R. Neuropeptide Y and Drug Development. 1997;57-86 Academic Press, San Diego.
9. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418.
10. Erickson J.C., Ahima R.S., Hollopeter G., Flier J.S., Palmiter R.D. Endocrine function of the neuropeptide Y knockout mice. Reg. Peptides. 70:1997;199-202.
11. Flood J.F., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y. Brain Res. 421:1987;280-290.
12. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. P.S.E.B.M. 218:1998;7-22.
13. Gold R.M., Jones A.P., Sawchenko P.E. Paraventricular area: critical focus of a longitudinal neurocircuitry mediating food intake. Physiol. Behav. 18:1977;1111-1119.
14. Hau X.-Y., Boublik J.H., Spicer M.A., Rivier J.E., Brown M.R., Yaksh T.L. The antinociceptive effects of spinally administered neuropeptide Y the rat: systematic studies on structure-activity relationship. J. Pharmacol. Exp. Ther. 258:1991;243-248.
15. Heilig M., Soderpalm B., Engel J.A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology. 98:1989;524-529.
16. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved. Trends Pharmaceut. Sci. 20:1999;43-46.
17. Jolicocur F.B., Michaud J.-N., Rivest R., Menard D., Gaudin D., Fournier A., St-Pierre S. Neurobehavioral profile of neuropeptide Y. Brain Res. Bull. 26:1991;265-268.
18. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Karlra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. 88:1991;10931-10935.
19. Kask A., Rago L., Harro J. Anxiolytic-like effect of neuropeptide (NPY) and NPY 13-36 microinjected into vacinity of locus coeruleus in rats. Brain Res. 788:1998;345-348.
20. Stress-induced analgesia. Kelly D.D. Ann. N.Y. Acad. Sci. 467:1986.
21. Leibowitz S.F. Hypothalamic paraventricular nucleus: Interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci., Biobehav. Rev. 12:1988;101-109.
22. Levine A.S., Morley J.E. Neuropeptide Y: A potent inducer of consummatory behavior in rats. Peptides. 5:1984;1025-1029.
23. Ling A.L. Neuropeptide Y receptor antagonsits. Exp. Opin. Ther. Patents. 9:1999;375-384.
24. Marsh D.J., Baraban S.C., Hollopeter G., Palmiter R.D. Role of the YS neuropeptide receptor in limbic seizures. Proc. Nati. Acad. Sci. 96:1999;13518-13523.
25. Mellado M.L., Givert-Rahola J., Lagares R., Chover A.J., Mico J.A. Effect on nociception of intracerebroventricular administration of low doses of neuropeptide Y in mice. Life Sci. 58:1996;2409-2414.
26. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:1958;254-260.
27. Nakajima M., Inui A., Teranishi A., Miura M., Hirosue Y., Okita M., Himori N., Baba S., Kasuga M. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J. Pharmacol. Exp. Ther. 268:1994;1010-1014.
28. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V., Arenas E., Gedda K., Svensson L., Thoren P., Emfors P. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Med. 5:1999;1188-1193.
29. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
30. Peterson J.M., Blum C.A., Cai G., Hutchinson A. WO 96/40660. 1996.
31. Ralph R.J., Varty G.B., Kelly M.A., Wang Y., Caron M.G., Rubinstein M., Grandy D.K., Low M.J., Geyer M.A. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J. Neurosci. 19:1999;4627-4633.
32. Simon P., Dupuis R., Constentin J. Thigmotaxis as an index of anxiety in mice: influence of dopaminergic transmission. Behav. Brain Res. 61:1994;59-64.
33. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
34. Thorsell A., Carlsson K., Ekman R., Heilig M. Behavioral and endocrine adaptation, and upregulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport. 10:1999;3003-3007.
35. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:1988;958-962.